Search For "phase 3"
Government eases norms on pricing, procurement, eligibility of COVID-19 va
Updated : 4 years, 11 months ago IST
New Delhi [India], April 19 (ANI): In a significant decision to check the surge in COVID-19 cases in the country and vaccinate largest section of population in shortest possible time, the government on Monday announced the decision to liberalise and accelerate the Phase 3 strategy of COVID-1
Read More
Regeneron antibody cocktail 'helps prevent' symptomatic Covid-19: Drugmake
Updated : 4 years, 11 months ago IST
New York [US], April 13 (ANI): New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said on Monday.
Read More
Pfizer-BioNTech COVID-19 vaccine protection lasts at least 'six months', p
Updated : 4 years, 11 months ago IST
New York [US], April 1 (ANI): The ongoing Phase 3 clinical trial of Pfizer/BioNTech's coronavirus vaccine has confirmed its protection lasts at least six months after the second dose.
Read More
Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat
Updated : 5 years ago IST
Hyderabad (Telangana) [India], March 3 (ANI): Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the drug demonstrating 81 per cent interim efficacy against Covid-19.
Read More
Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could b
Updated : 5 years ago IST
Paris [France], February 22 (ANI): Sanofi and GlaxoSmithKline (GSK) said on Monday they had begun a phase 2 trial of their COVID-19 vaccine candidates, and if results are positive, a phase 3 study could start in the second quarter of 2021.
Read More
Russia's Sputnik V COVID-19 vaccine 91.6 per cent effective: Lancet
Updated : 5 years, 1 month ago IST
Moscow [Russia], February 2 (ANI): Russian's Sputnik V is 91.6 per cent effective at protecting people from COVID-19, according to the result of an interim analysis of the phase 3 trials published by the journal Lancet on Tuesday.
Read More
COVID-19 vaccine of US company Novavax shows 89.3 pc efficacy in phase 3 t
Updated : 5 years, 1 month ago IST
Maryland [US], January 29 (ANI/Sputnik): The coronavirus vaccine developed by the US company Novavax has demonstrated 89.3 per cent efficacy during the phase 3 trials conducted in the United Kingdom, the company said in a statement.
Read More
Russian COVID-19 vaccine in phase 3 trial, to cost below USD 10 per shot i
Updated : 5 years, 1 month ago IST
New Delhi [India], January 21 (ANI): The Russian COVID-19 vaccine 'Sputnik V' will cost less than USD 10 (about Rs 730) per shot in India and the price is the same for all countries, Kirill Dmitriev, CEO of Russian Direct Investment Fund (RDIF) said on Thursday.
Read More
Indians are not guinea pigs, you can't use Covaxin rollout as phase 3 tria
Updated : 5 years, 2 months ago IST
New Delhi [India], January 14 (ANI): Congress leader Manish Tewari on Wednesday said that emergency use authorization to COVID-19 vaccine 'Covaxin' raises concerns on its efficacy as phase three trials have not been completed and its roll out can't be used as phase three trial. He said India
Read More
Bird Flu: 35 crows found dead in Delhi, samples collected for testing
Updated : 5 years, 2 months ago IST
New Delhi [India], January 9 (ANI): As many as 17 crows were found dead at a park in Delhi's Mayur Vihar Phase 3, two at a DDA park in Dwarka, and 16 in Hastsal village of West district on Saturday, following which the Delhi government collected samples to investigate for avian influenza tha
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clin
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More